Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
1897
-
Total 13F shares, excl. options
-
2.04B
-
Shares change
-
+182M
-
Total reported value, excl. options
-
$130B
-
Value change
-
+$11.6B
-
Put/Call ratio
-
0.82
-
Number of buys
-
833
-
Number of sells
-
-870
-
Price
-
$63.54
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q1 2017
2,042 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q1 2017.
Merck & Co., Inc. - Common Stock (MRK) has 1,897 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.04B shares
of 2.53B outstanding shares and own 80.67% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (191M shares), BlackRock Inc. (183M shares), STATE STREET CORP (123M shares), WELLINGTON MANAGEMENT GROUP LLP (116M shares), Capital World Investors (107M shares), PRICE T ROWE ASSOCIATES INC /MD/ (51.3M shares), Bank of New York Mellon Corp (43.1M shares), JPMORGAN CHASE & CO (36M shares), NORTHERN TRUST CORP (35.9M shares), and BANK OF AMERICA CORP /DE/ (35.8M shares).
This table shows the top 1897 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.